Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Renin-Angiotensin-System (RAS)-Acting Agent market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Angiotensin Converting Enzyme Inhibitors (ACEi) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Renin-Angiotensin-System (RAS)-Acting Agent include Novartis AG, Pfizer, Inc., AstraZeneca plc, Merck & Co., Inc., Sanofi S.A., Bristol-Myers Squibb Company, Daiichi Sankyo Company,Limited, Takeda Pharmaceutical Company Limited and Boehringer lngelheim GmbH, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Renin-Angiotensin-System (RAS)-Acting Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renin-Angiotensin-System (RAS)-Acting Agent. This report contains market size and forecasts of Renin-Angiotensin-System (RAS)-Acting Agent in global, including the following market information:
Global Renin-Angiotensin-System (RAS)-Acting Agent Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Renin-Angiotensin-System (RAS)-Acting Agent Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Renin-Angiotensin-System (RAS)-Acting Agent companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Renin-Angiotensin-System (RAS)-Acting Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Renin-Angiotensin-System (RAS)-Acting Agent Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent Market Segment Percentages, by Type, 2022 (%)
Angiotensin Converting Enzyme Inhibitors (ACEi)
Angiotensin Receptor Blockers (ARBs)
Global Renin-Angiotensin-System (RAS)-Acting Agent Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent Market Segment Percentages, by Application, 2022 (%)
Hypertension
Heart Failure
Chronic Kidney Disease
Other
Global Renin-Angiotensin-System (RAS)-Acting Agent Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Renin-Angiotensin-System (RAS)-Acting Agent revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Renin-Angiotensin-System (RAS)-Acting Agent revenues share in global market, 2022 (%)
Key companies Renin-Angiotensin-System (RAS)-Acting Agent sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Renin-Angiotensin-System (RAS)-Acting Agent sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Sanofi S.A.
Bristol-Myers Squibb Company
Daiichi Sankyo Company,Limited
Takeda Pharmaceutical Company Limited
Boehringer lngelheim GmbH
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Renin-Angiotensin-System (RAS)-Acting Agent, market overview.
Chapter 2: Global Renin-Angiotensin-System (RAS)-Acting Agent market size in revenue and volume.
Chapter 3: Detailed analysis of Renin-Angiotensin-System (RAS)-Acting Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Renin-Angiotensin-System (RAS)-Acting Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Renin-Angiotensin-System (RAS)-Acting Agent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Renin-Angiotensin-System (RAS)-Acting Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Renin-Angiotensin-System (RAS)-Acting Agent Overall Market Size
2.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Market Size: 2022 VS 2029
2.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales: 2018-2029
3 Company Landscape
3.1 Top Renin-Angiotensin-System (RAS)-Acting Agent Players in Global Market
3.2 Top Global Renin-Angiotensin-System (RAS)-Acting Agent Companies Ranked by Revenue
3.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue by Companies
3.4 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales by Companies
3.5 Global Renin-Angiotensin-System (RAS)-Acting Agent Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Renin-Angiotensin-System (RAS)-Acting Agent Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Renin-Angiotensin-System (RAS)-Acting Agent Players in Global Market
3.8.1 List of Global Tier 1 Renin-Angiotensin-System (RAS)-Acting Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Renin-Angiotensin-System (RAS)-Acting Agent Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Renin-Angiotensin-System (RAS)-Acting Agent Market Size Markets, 2022 & 2029
4.1.2 Angiotensin Converting Enzyme Inhibitors (ACEi)
4.1.3 Angiotensin Receptor Blockers (ARBs)
4.2 By Type - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue & Forecasts
4.2.1 By Type - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2018-2023
4.2.2 By Type - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2024-2029
4.2.3 By Type - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue Market Share, 2018-2029
4.3 By Type - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales & Forecasts
4.3.1 By Type - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2018-2023
4.3.2 By Type - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2024-2029
4.3.3 By Type - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Market Share, 2018-2029
4.4 By Type - Global Renin-Angiotensin-System (RAS)-Acting Agent Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2022 & 2029
5.1.2 Hypertension
5.1.3 Heart Failure
5.1.4 Chronic Kidney Disease
5.1.5 Other
5.2 By Application - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue & Forecasts
5.2.1 By Application - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2018-2023
5.2.2 By Application - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2024-2029
5.2.3 By Application - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue Market Share, 2018-2029
5.3 By Application - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales & Forecasts
5.3.1 By Application - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2018-2023
5.3.2 By Application - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2024-2029
5.3.3 By Application - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Market Share, 2018-2029
5.4 By Application - Global Renin-Angiotensin-System (RAS)-Acting Agent Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2022 & 2029
6.2 By Region - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue & Forecasts
6.2.1 By Region - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2018-2023
6.2.2 By Region - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2024-2029
6.2.3 By Region - Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue Market Share, 2018-2029
6.3 By Region - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales & Forecasts
6.3.1 By Region - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2018-2023
6.3.2 By Region - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2024-2029
6.3.3 By Region - Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2018-2029
6.4.2 By Country - North America Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2018-2029
6.4.3 US Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.4.4 Canada Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.4.5 Mexico Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2018-2029
6.5.2 By Country - Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2018-2029
6.5.3 Germany Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.5.4 France Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.5.5 U.K. Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.5.6 Italy Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.5.7 Russia Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.5.8 Nordic Countries Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.5.9 Benelux Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2018-2029
6.6.2 By Region - Asia Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2018-2029
6.6.3 China Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.6.4 Japan Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.6.5 South Korea Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.6.6 Southeast Asia Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.6.7 India Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2018-2029
6.7.2 By Country - South America Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2018-2029
6.7.3 Brazil Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.7.4 Argentina Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales, 2018-2029
6.8.3 Turkey Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.8.4 Israel Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.8.5 Saudi Arabia Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
6.8.6 UAE Renin-Angiotensin-System (RAS)-Acting Agent Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Major Product Offerings
7.1.4 Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Sales and Revenue in Global (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Pfizer, Inc.
7.2.1 Pfizer, Inc. Company Summary
7.2.2 Pfizer, Inc. Business Overview
7.2.3 Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Major Product Offerings
7.2.4 Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer, Inc. Key News & Latest Developments
7.3 AstraZeneca plc
7.3.1 AstraZeneca plc Company Summary
7.3.2 AstraZeneca plc Business Overview
7.3.3 AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Major Product Offerings
7.3.4 AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca plc Key News & Latest Developments
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Company Summary
7.4.2 Merck & Co., Inc. Business Overview
7.4.3 Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Major Product Offerings
7.4.4 Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co., Inc. Key News & Latest Developments
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Company Summary
7.5.2 Sanofi S.A. Business Overview
7.5.3 Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Major Product Offerings
7.5.4 Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi S.A. Key News & Latest Developments
7.6 Bristol-Myers Squibb Company
7.6.1 Bristol-Myers Squibb Company Company Summary
7.6.2 Bristol-Myers Squibb Company Business Overview
7.6.3 Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Major Product Offerings
7.6.4 Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Sales and Revenue in Global (2018-2023)
7.6.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.7 Daiichi Sankyo Company,Limited
7.7.1 Daiichi Sankyo Company,Limited Company Summary
7.7.2 Daiichi Sankyo Company,Limited Business Overview
7.7.3 Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Major Product Offerings
7.7.4 Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Sales and Revenue in Global (2018-2023)
7.7.5 Daiichi Sankyo Company,Limited Key News & Latest Developments
7.8 Takeda Pharmaceutical Company Limited
7.8.1 Takeda Pharmaceutical Company Limited Company Summary
7.8.2 Takeda Pharmaceutical Company Limited Business Overview
7.8.3 Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Major Product Offerings
7.8.4 Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Sales and Revenue in Global (2018-2023)
7.8.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.9 Boehringer lngelheim GmbH
7.9.1 Boehringer lngelheim GmbH Company Summary
7.9.2 Boehringer lngelheim GmbH Business Overview
7.9.3 Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Major Product Offerings
7.9.4 Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Sales and Revenue in Global (2018-2023)
7.9.5 Boehringer lngelheim GmbH Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Major Product Offerings
7.10.4 Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Sales and Revenue in Global (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
8 Global Renin-Angiotensin-System (RAS)-Acting Agent Production Capacity, Analysis
8.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Production Capacity, 2018-2029
8.2 Renin-Angiotensin-System (RAS)-Acting Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Renin-Angiotensin-System (RAS)-Acting Agent Supply Chain Analysis
10.1 Renin-Angiotensin-System (RAS)-Acting Agent Industry Value Chain
10.2 Renin-Angiotensin-System (RAS)-Acting Agent Upstream Market
10.3 Renin-Angiotensin-System (RAS)-Acting Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Renin-Angiotensin-System (RAS)-Acting Agent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
